Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4293322
Max Phase: Preclinical
Molecular Formula: C12H14N4O2S
Molecular Weight: 278.34
Molecule Type: Small molecule
Associated Items:
ID: ALA4293322
Max Phase: Preclinical
Molecular Formula: C12H14N4O2S
Molecular Weight: 278.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC1=NN(C(C)=O)C(C)(c2ccncc2)S1
Standard InChI: InChI=1S/C12H14N4O2S/c1-8(17)14-11-15-16(9(2)18)12(3,19-11)10-4-6-13-7-5-10/h4-7H,1-3H3,(H,14,15,17)
Standard InChI Key: YSVMCOKTUYMRHA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 278.34 | Molecular Weight (Monoisotopic): 278.0837 | AlogP: 1.26 | #Rotatable Bonds: 1 |
Polar Surface Area: 74.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.68 | CX Basic pKa: 4.98 | CX LogP: 0.58 | CX LogD: 0.58 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.84 | Np Likeness Score: -0.68 |
1. Talapatra SK, Tham CL, Guglielmi P, Cirilli R, Chandrasekaran B, Karpoormath R, Carradori S, Kozielski F.. (2018) Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors., 156 [PMID:30031975] [10.1016/j.ejmech.2018.07.006] |
Source(1):